Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Gross Profit (2022 - 2025)

Historic Gross Profit for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $9.7 million.

  • TriSalus Life Sciences' Gross Profit rose 5224.59% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.8 million, marking a year-over-year increase of 4425.75%. This contributed to the annual value of $25.3 million for FY2024, which is 5923.55% up from last year.
  • As of Q3 2025, TriSalus Life Sciences' Gross Profit stood at $9.7 million, which was up 5224.59% from $9.4 million recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Gross Profit ranged from a high of $9.7 million in Q3 2025 and a low of $2.3 million during Q1 2023
  • Its 4-year average for Gross Profit is $5.7 million, with a median of $5.5 million in 2024.
  • Within the past 5 years, the most significant YoY rise in TriSalus Life Sciences' Gross Profit was 13626.18% (2024), while the steepest drop was 3708.89% (2024).
  • Quarter analysis of 4 years shows TriSalus Life Sciences' Gross Profit stood at $2.4 million in 2022, then soared by 113.24% to $5.1 million in 2023, then surged by 37.09% to $7.0 million in 2024, then surged by 37.12% to $9.7 million in 2025.
  • Its Gross Profit was $9.7 million in Q3 2025, compared to $9.4 million in Q2 2025 and $7.7 million in Q1 2025.